Impact of different carbapenems and regimens of administration on resistance emergence for three isogenic Pseudomonas aeruginosa strains with differing mechanisms of resistance
about
Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1Relationship between ceftolozane-tazobactam exposure and selection for Pseudomonas aeruginosa resistance in a hollow-fiber infection modelNovel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumanniiGenetic and biochemical characterization of an acquired subgroup B3 metallo-β-lactamase gene, blaAIM-1, and its unique genetic context in Pseudomonas aeruginosa from AustraliaStructure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies.Optimization of Synergistic Combination Regimens against Carbapenem- and Aminoglycoside-Resistant Clinical Pseudomonas aeruginosa Isolates via Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling.Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant enterococci: Three major threats to hematopoietic stem cell transplant recipients.The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies.Predicting and preventing antimicrobial resistance utilizing pharmacodynamics: part II Gram-negative bacteria.Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model.Evaluation of ceftobiprole activity against a variety of gram-negative pathogens, including Escherichia coli, Haemophilus influenzae (β-lactamase positive and β-lactamase negative), and Klebsiella pneumoniae, in a rabbit meningitis model.Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling.Pharmacokinetics of doripenem during high volume hemodiafiltration in patients with septic shock.Comparative pharmacodynamics and antimutant potentials of doripenem and imipenem with ciprofloxacin-resistant Pseudomonas aeruginosa in an in vitro model.In vitro susceptibility of characterized β-lactamase-producing strains tested with avibactam combinations.Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and Modeling.
P2860
Q26771850-2CE74454-CECC-42B0-A50B-D9449B4F2930Q34298994-E5048331-F3FE-4F1C-BF14-9B49462B07A8Q35168931-2EC8B156-871C-4BE3-A5C2-BE6C92C39C02Q36396124-CE3AE568-36BC-4872-ABE1-1DCE194BBBACQ37317645-FE23D6FB-AB80-42D6-8844-A6B595DA610AQ37538623-42ADFE51-A451-4440-9408-69194DFF4D33Q38620812-20D8E500-C1FF-4283-8550-E3614B0FFFCCQ38875315-ED3C5B74-DE25-4516-836F-141CD6755E0AQ39293585-64BF6A1F-A6E8-4D4A-A4E2-2C5A83B40976Q40306198-3D610EA2-1C90-4530-A18F-D4B2A185935EQ40600643-9959146E-2DD7-4241-9BA1-E033D96C7063Q40657200-9C00492B-B68E-4CC8-8918-846BBDC778E4Q41656519-7CADC074-2810-4BD2-966E-D7D18545215AQ42598770-5EA96FC8-17BA-464B-9427-88665FDF0C95Q43144149-A5D9D3C5-FF5C-4A18-9C66-33FD8245F7C5Q47691167-C1906C98-7BA1-49E5-AF86-13687639F598
P2860
Impact of different carbapenems and regimens of administration on resistance emergence for three isogenic Pseudomonas aeruginosa strains with differing mechanisms of resistance
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Impact of different carbapenem ...... ering mechanisms of resistance
@ast
Impact of different carbapenem ...... ering mechanisms of resistance
@en
type
label
Impact of different carbapenem ...... ering mechanisms of resistance
@ast
Impact of different carbapenem ...... ering mechanisms of resistance
@en
prefLabel
Impact of different carbapenem ...... ering mechanisms of resistance
@ast
Impact of different carbapenem ...... ering mechanisms of resistance
@en
P2093
P2860
P356
P1476
Impact of different carbapenem ...... ering mechanisms of resistance
@en
P2093
Anne-Marie Queenan
Arnold Louie
Brian Morrow
Brian Van Scoy
Christine Fregeau
David Brown
G L Drusano
James B Kahn
Karen Bush
P2860
P304
P356
10.1128/AAC.01721-09
P407
P577
2010-03-22T00:00:00Z